CellWell record HH-469347
Genetic Determinants of Sex Hormones and SHBG Across Menopausal Stages and Hormone Replacement Therapy Use: Implications for Endometrial Cancer Risk
Yaqi Alexandra Deng; Åsa Johansson; Torgny Karlsson; Simon Henning
2026
In plain language
Mendelian randomization in UK Biobank women found that higher SHBG was inversely associated with endometrial cancer risk outside hormone therapy, while the testosterone link weakened after adjustment.
- Evidence
- Emerging
- Design
- Preprint
Cite this record: https://thecellwell.org/studies/HH-469347
Produced by the CellWell Research Engine, custom software owned and operated by CellWell. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.